The dosing is closely targeted by this pen, and the patient can easily, comfortably, and accurately administer it to themselves
Regarding medication management, for patients with clinical cardiovascular disease, a sodiumglucose cotransporter-2 (SGLT2) inhibitor or a glucagon-like peptide-1 (GLP-1) receptor agonist with proven cardiovascular benefit is recommended
Ive written about the science and statistics and studies related to Maintenance before (read here about weight regain and here for some more science) but not necessarily my own experience with it
If youre experiencing severe symptoms, work with your doctor to determine whether continuing is appropriate
doi: 10.1016/j.clnu.2008.06.013
1 And some of the change holds: produce and a few other categories stay elevated even after people come off the drug, and half of those who stop expect to go back on it